A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

BORDEAUX-GLIO is a prospective, monocentric study which will describe the molecular, immune and metabolic pathways involved in the progression and relapse of glioblastoma, using blood and tumor samples from patients who have undergone surgery for newly diagnosed or recurrent glioblastoma in the center.

Inclusion Criteria: * Patients of 18 years or older, with highly suspected glioblastoma on neuro-imagery * Planned surgical tumor resection, * No objection to participate in research * Signed genetic consent Exclusion Criteria: * Patients under guardianship, curatorship or protective supervision * Taking immunosuppressants * Pregnant or breast-feeding women * Patients deprived of their liberty by judicial or administrative decision, or under psychiatric care